Juan Carlos Izpisua Belmonte of the Salk Institute for Biological Studies, whose lab was involved in a recent, successful effort to correct a gene mutation in human embryos, is one of a number of distinguished speakers participating in the upcoming Cell Symposia on CRISPR: From Biology to Technology and Novel Therapeutics. The conference, organized by Cell Press, takes place October 22-24, 2017, in Sitges, Spain.
The event will provide a comprehensive view of CRISPR as an entire field, including talks from microbiologists, biochemists, structural biologists, and scientists who are developing and using CRISPR technologies for therapeutic/agricultural benefit. Participants will hear about work that will inspire new generations of CRISPR-based tools and gain a broader appreciation for the intricacies of applying CRISPR technology.
"CRISPR systems have evolved to protect microbes from phage invaders but have recently been repurposed by scientists as powerful tools for biological discovery and biotechnology," says co-organizer John Pham, editor of the journal Molecular Cell. "Building on recent accomplishments in gene editing to unleash the full potential of CRISPR-based technologies will require a deeper understanding of the basic biology of how these systems work."
Speakers include:
- Charlie Albright, Chief Scientific Officer, Editas Medicine,USA
- Chase Beisel, North Carolina State University, USA
- Paula Cannon, University of Southern California, USA
- Jacob Corn, University of California, Berkeley, USA
- Alan Davidson, University of Toronto, Canada
- Charles Gersbach, Duke University, USA
- Maria Jasin, Sloan-Kettering Cancer Center, USA
- Martin Jinek, University of Zurich, Switzerland
- J. Keith Joung, Massachusetts General Hospital, Harvard Medical School, USA
- Nancy Maizels, University of Washington, USA
- Andy May, Chan-Zuckerberg BioHub, USA
- Francisco Mojica, Department of Physiology, Genetic and Microbiology at Universidad de Alicante, SpainLuigi Naldini, Telethon Institute Milan, Italy
- Tony Nolan, Imperial College London, UK
- John van der Oost, Waginengen University, The Netherlands
- Michel Sadelain, Sloan Kettering Cancer Center, USA
- Blake Wiedenheft, Montana State University, USA
Further information and registration can be found on the symposium website http://cell-symposia.com/crispr-2017/default.asp.
###
Cell Symposia (@CellSymposia), are organized by the editors of Cell Press' leading journals. The conferences bring together exceptional speakers and scientists to discuss topics at the forefront of scientific research. Other Cell Symposia in 2017 include: Exercise Metabolism; Cancer, Inflammation, and Immunity; Neuro-Immune Axis: Reciprocal Regulation in Development, Health, and Disease; Emerging and Reemerging Viruses; Human Immunity; Metabolic Disease Therapies; and Big Questions in Neuroscience. Visit http://cell-symposia.com/.
Media Contact
Joseph Caputo
[email protected]
617-335-6270
@CellPressNews
http://www.cellpress.com
